Variation in tau isoform expression in different brain regions and disease states

Neurobiol Aging. 2013 Jul;34(7):1922.e7-1922.e12. doi: 10.1016/j.neurobiolaging.2013.01.017. Epub 2013 Feb 19.

Abstract

Progressive supranuclear palsy (PSP) is the most common atypical parkinsonian disorder. Abnormal tau inclusions, in selected regions of the brain, are a hallmark of the disease and the H1 haplotype of MAPT, the gene encoding tau, is the major risk factor in PSP. A 3-repeat and 4-repeat (4R) tau isoform ratio imbalance has been strongly implicated as a cause of disease. Thus, understanding tau isoform regional expression in disease and pathology-free states is crucial to elucidating the mechanisms involved in PSP and other tauopathies. We used a tau isoform-specific fluorescent assay to investigate relative 4R-tau expression in 6 different brain regions in PSP cases and healthy control samples. We identified a marked difference in 4R-tau relative expression, across brain regions and between MAPT haplotypes. Highest 4R-tau expression levels were identified in the globus pallidus compared with pons, cerebellum, and frontal cortex. 4R-tau expression levels were related to the MAPT H1 and H1c haplotypes. Similar regional variation was seen in PSP case and in control samples.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Chemistry / genetics*
  • Case-Control Studies
  • Female
  • Gene Expression Regulation*
  • Globus Pallidus / metabolism
  • Globus Pallidus / pathology
  • Humans
  • Male
  • Middle Aged
  • Protein Isoforms / biosynthesis
  • Protein Isoforms / genetics
  • Supranuclear Palsy, Progressive / diagnosis
  • Supranuclear Palsy, Progressive / genetics
  • Supranuclear Palsy, Progressive / metabolism*
  • Young Adult
  • tau Proteins / biosynthesis
  • tau Proteins / genetics*

Substances

  • Protein Isoforms
  • tau Proteins